{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:51:45Z","timestamp":1781232705129,"version":"3.54.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T00:00:00Z","timestamp":1547856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T00:00:00Z","timestamp":1547856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00520-018-4632-0","type":"journal-article","created":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T20:03:26Z","timestamp":1547928206000},"page":"3439-3447","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Assessment of baseline symptom burden in treatment-na\u00efve patients with lung cancer: an observational study"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8122-5233","authenticated-orcid":false,"given":"Tito R.","family":"Mendoza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"Kehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwatosin","family":"Bamidele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuling","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Cleeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,19]]},"reference":[{"issue":"5","key":"4632_CR1","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/cncr.29097","volume":"121","author":"EY Hanna","year":"2015","unstructured":"Hanna EY, Mendoza TR, Rosenthal DI, Gunn GB, Sehra P, Yucel E, Cleeland CS (2015) The symptom burden of treatment-naive patients with head and neck cancer. Cancer 121(5):766\u2013773. \n                              https:\/\/doi.org\/10.1002\/cncr.29097","journal-title":"Cancer"},{"issue":"7","key":"4632_CR2","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V","volume":"89","author":"CS Cleeland","year":"2000","unstructured":"Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M, Engstrom MC (2000) Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer 89(7):1634\u20131646. \n                              https:\/\/doi.org\/10.1002\/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V","journal-title":"Cancer"},{"issue":"7","key":"4632_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/dju129","volume":"106","author":"BB Reeve","year":"2014","unstructured":"Reeve BB, Mitchell SA, Dueck AC, Basch E, Cella D, Reilly CM, Minasian LM, Denicoff AM, O\u2019Mara AM, Fisch MJ, Chauhan C, Aaronson NK, Coens C, Bruner DW (2014) Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst 106(7):1\u20138. \n                              https:\/\/doi.org\/10.1093\/jnci\/dju129","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"4632_CR4","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/hed.20602","volume":"29","author":"DI Rosenthal","year":"2007","unstructured":"Rosenthal DI, Mendoza TR, Chambers MS, Asper JA, Gning I, Kies MS, Weber RS, Lewin JS, Garden AS, Ang KK, Wang XS, Cleeland CS (2007) Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck 29(10):923\u2013931. \n                              https:\/\/doi.org\/10.1002\/hed.20602","journal-title":"Head Neck"},{"issue":"2","key":"4632_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1634\/theoncologist.2010-0193","volume":"16","author":"TR Mendoza","year":"2011","unstructured":"Mendoza TR, Wang XS, Lu C, Palos GR, Liao Z, Mobley GM, Kapoor S, Cleeland CS (2011) Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M.D. Anderson Symptom Inventory. Oncologist 16(2):217\u2013227. \n                              https:\/\/doi.org\/10.1634\/theoncologist.2010-0193","journal-title":"Oncologist"},{"issue":"1","key":"4632_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11060-006-9135-z","volume":"80","author":"TS Armstrong","year":"2006","unstructured":"Armstrong TS, Mendoza T, Gning I, Coco C, Cohen MZ, Eriksen L, Hsu MA, Gilbert MR, Cleeland C (2006) Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT). J Neuro-Oncol 80(1):27\u201335. \n                              https:\/\/doi.org\/10.1007\/s11060-006-9135-z","journal-title":"J Neuro-Oncol"},{"issue":"8","key":"4632_CR7","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1002\/cncr.24920","volume":"116","author":"XS Wang","year":"2010","unstructured":"Wang XS, Williams LA, Eng C, Mendoza TR, Shah NA, Kirkendoll KJ, Shah PK, Trask PC, Palos GR, Cleeland CS (2010) Validation and application of a module of the M.D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI). Cancer 116(8):2053\u20132063. \n                              https:\/\/doi.org\/10.1002\/cncr.24920","journal-title":"Cancer"},{"issue":"1","key":"4632_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/030089160709300111","volume":"93","author":"AN Annakkaya","year":"2007","unstructured":"Annakkaya AN, Arbak P, Balbay O, Bilgin C, Erbas M, Bulut I (2007) Effect of symptom-to-treatment interval on prognosis in lung cancer. Tumori 93(1):61\u201367. \n                              https:\/\/doi.org\/10.1700\/264.3004","journal-title":"Tumori"},{"issue":"3","key":"4632_CR9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/bjc.1995.124","volume":"71","author":"P Hopwood","year":"1995","unstructured":"Hopwood P, Stephens RJ (1995) Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. Br J Cancer 71(3):633\u2013636. \n                              https:\/\/doi.org\/10.1038\/bjc.1995.124","journal-title":"Br J Cancer"},{"issue":"5","key":"4632_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.cllc.2011.11.010","volume":"13","author":"E Giroux Leprieur","year":"2012","unstructured":"Giroux Leprieur E, Labrune S, Giraud V, Gendry T, Cobarzan D, Chinet T (2012) Delay between the initial symptoms, the diagnosis and the onset of specific treatment in elderly patients with lung cancer. Clin Lung Cancer 13(5):363\u2013368. \n                              https:\/\/doi.org\/10.1016\/j.cllc.2011.11.010","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"4632_CR11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.20344\/amp.4229","volume":"27","author":"FJ Gonzalez-Barcala","year":"2014","unstructured":"Gonzalez-Barcala FJ, Falagan JA, Garcia-Prim JM, Valdes L, Carreira JM, Pose A, Canive JC, Anton D, Garcia-Sanz MT, Puga A, Temes E, Lopez-Lopes R (2014) Symptoms and reason for a medical visit in lung cancer patients. Acta Medica Port 27(3):318\u2013324","journal-title":"Acta Medica Port"},{"key":"4632_CR12","unstructured":"Cleeland CS (2014). The MD Anderson Symptom Inventory user guide. Department of Symptom Research, The University of Texas MD Anderson Cancer Center. \n                              https:\/\/www.mdanderson.org\/documents\/Departments-and-Divisions\/Symptom-Research\/MDASI_userguide.pdf\n                              \n                           . Accessed April 2, 2018"},{"issue":"27","key":"4632_CR13","doi-asserted-by":"publisher","first-page":"6682","DOI":"10.1200\/JCO.2005.10.728","volume":"23","author":"DR Buchanan","year":"2005","unstructured":"Buchanan DR, White JD, O\u2019Mara AM, Kelaghan JW, Smith WB, Minasian LM (2005) Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience. J Clin Oncol 23(27):6682\u20136689. \n                              https:\/\/doi.org\/10.1200\/JCO.2005.10.728","journal-title":"J Clin Oncol"},{"issue":"11","key":"4632_CR14","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1200\/JCO.1998.16.11.3662","volume":"16","author":"JA Sloan","year":"1998","unstructured":"Sloan JA, Loprinzi CL, Kuross SA, Miser AW, O\u2019Fallon JR, Mahoney MR, Heid IM, Bretscher ME, Vaught NL (1998) Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol 16(11):3662\u20133673. \n                              https:\/\/doi.org\/10.1200\/JCO.1998.16.11.3662","journal-title":"J Clin Oncol"},{"issue":"2","key":"4632_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0304-3959(94)00178-H","volume":"61","author":"RC Serlin","year":"1995","unstructured":"Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS (1995) When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 61(2):277\u2013284. \n                              https:\/\/doi.org\/10.1016\/0304-3959(94)00178-H","journal-title":"Pain"},{"issue":"1\u20132","key":"4632_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.pain.2004.10.024","volume":"113","author":"KO Anderson","year":"2005","unstructured":"Anderson KO (2005) Role of cutpoints: why grade pain intensity? Pain 113(1\u20132):5\u20136. \n                              https:\/\/doi.org\/10.1016\/j.pain.2004.10.024","journal-title":"Pain"},{"issue":"2","key":"4632_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/cncr.27744","volume":"119","author":"CS Cleeland","year":"2013","unstructured":"Cleeland CS, Sloan JA, Cella D, Chen C, Dueck AC, Janjan NA, Liepa AM, Mallick R, O\u2019Mara A, Pearson JD, Torigoe Y, Wang XS, Williams LA, Woodruff JF (2013) Recommendations for including multiple symptoms as endpoints in cancer clinical trials: a report from the ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task Force. Cancer 119(2):411\u2013420. \n                              https:\/\/doi.org\/10.1002\/cncr.27744","journal-title":"Cancer"},{"issue":"1","key":"4632_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jpain.2005.07.012","volume":"7","author":"GR Palos","year":"2006","unstructured":"Palos GR, Mendoza TR, Mobley GM, Cantor SB, Cleeland CS (2006) Asking the community about cutpoints used to describe mild, moderate, and severe pain. J Pain 7(1):49\u201356. \n                              https:\/\/doi.org\/10.1016\/j.jpain.2005.07.012","journal-title":"J Pain"},{"issue":"5","key":"4632_CR19","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N","volume":"85","author":"TR Mendoza","year":"1999","unstructured":"Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL (1999) The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 85(5):1186\u20131196. \n                              https:\/\/doi.org\/10.1002\/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N","journal-title":"Cancer"},{"issue":"1\u20132","key":"4632_CR20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000320607","volume":"79","author":"TR Mendoza","year":"2010","unstructured":"Mendoza TR, Laudico AV, Wang XS, Guo H, Matsuda ML, Yosuico VD, Fragante EP, Cleeland CS (2010) Assessment of fatigue in cancer patients and community dwellers: validation study of the Filipino version of the brief fatigue inventory. Oncology 79(1\u20132):112\u2013117. \n                              https:\/\/doi.org\/10.1159\/000320607","journal-title":"Oncology"},{"issue":"4","key":"4632_CR21","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/cncr.27789","volume":"119","author":"CS Cleeland","year":"2013","unstructured":"Cleeland CS, Body JJ, Stopeck A, von Moos R, Fallowfield L, Mathias SD, Patrick DL, Clemons M, Tonkin K, Masuda N, Lipton A, de Boer R, Salvagni S, Oliveira CT, Qian Y, Jiang Q, Dansey R, Braun A, Chung K (2013) Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid. Cancer 119(4):832\u2013838. \n                              https:\/\/doi.org\/10.1002\/cncr.27789","journal-title":"Cancer"},{"issue":"4","key":"4632_CR22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1200\/JOP.2013.001276","volume":"10","author":"JM Hubbard","year":"2014","unstructured":"Hubbard JM, Grothey AF, McWilliams RR, Buckner JC, Sloan JA (2014) Physician perspective on incorporation of oncology patient quality-of-life, fatigue, and pain assessment into clinical practice. J Oncol Pract 10(4):248\u2013253. \n                              https:\/\/doi.org\/10.1200\/JOP.2013.001276","journal-title":"J Oncol Pract"},{"key":"4632_CR23","unstructured":"AJCC Cancer Staging Manual (2017) 8th edn. Springer International Publishing, Cham"},{"issue":"8","key":"4632_CR24","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1000678","volume":"363","author":"JS Temel","year":"2010","unstructured":"Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363(8):733\u2013742. \n                              https:\/\/doi.org\/10.1056\/NEJMoa1000678","journal-title":"N Engl J Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4632-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-018-4632-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4632-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T15:19:21Z","timestamp":1589642361000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-018-4632-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,19]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["4632"],"URL":"https:\/\/doi.org\/10.1007\/s00520-018-4632-0","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,19]]},"assertion":[{"value":"7 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by our Institutional Review Board. As this was a retrospective review of deidentified data, the requirement for informed consent was waived.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The MD Anderson Symptom Inventory is copyrighted and licensed by The University of Texas MD Anderson Cancer Center and Charles S. Cleeland. The authors report no other conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}